UBS Group AG (UBS): Q1 2026 Net Profit Jumps +80% on Wealth Management and Investment Bank Strength
Key Takeaways
- UBS Group AG (UBS) posted a first-quarter 2026 net profit attributable to shareholders of $3.0 billion, up 80% from the prior year and well above consensus estimates of around $2.3 billion.
- Return on Common Equity Tier 1 capital (RoCET1) reached 16.8%, with an underlying figure of 17.0%.
- Total revenues climbed 13% year-over-year to $14.2 billion, driven by robust performance in Global Wealth Management (GWM) and Investment Bank divisions.
- Earnings per share (EPS) of $0.94 surpassed analyst expectations of $0.83.
- GWM recorded net new assets of $37 billion; Asset Management saw $14 billion in net new money.
- CET1 capital ratio stood at 14.7%, supporting ongoing share repurchases totaling $0.9 billion in the quarter.
Earnings Context and Why It Matters
UBS Group AG's (UBS) first-quarter 2026 earnings offer a clear window into the bank's progress following its Credit Suisse integration, even in a tough macroeconomic backdrop. As a leading global wealth manager and investment bank, these results demonstrate resilience in client engagement, disciplined cost management, and solid capital position. From what I see, investors pay close attention to these updates for clues on wealth inflows, trading activity, and key metrics like CET1 capital, which support future dividends and buybacks. This strong showing bolsters UBS's position in a higher-for-longer rate environment, with implications for peers across the European banking sector.
Reported Results
UBS Group AG (UBS) put up impressive first-quarter 2026 numbers, with net profit attributable to shareholders hitting $3.040 billion—a sharp 80% increase year-over-year that handily beat analyst estimates of about $2.326 billion. Total revenues grew 13% to $14.243 billion, aided by foreign currency gains and partially offset by other items; this came in roughly 4.9% ahead of consensus.
EPS landed at $0.94, topping expectations of $0.83-$0.84. Standout performances came from key divisions: GWM's transaction-based income rose 17%, alongside $37 billion in net new assets; Investment Bank revenues surged 27% thanks to record Global Markets and strong Global Banking volumes; Asset Management brought in $14 billion in net new money. The CET1 capital ratio held at 14.7% (with a 4.4% leverage ratio), and cumulative cost savings reached $11.5 billion. No new formal guidance was given apart from buyback intentions, but underlying profit before tax was $3.990 billion against a $3.270 billion consensus. I also checked this using Tickeron’s AI Screener to gauge how UBS compares to industry peers on these metrics.
Market Reaction and Investor Sentiment
The market responded favorably to UBS's strong results, with shares gaining traction in early European and U.S. trading after the pre-market announcement. Investors viewed the profit beat and capital robustness as confirmation of the successful Credit Suisse merger and ongoing client momentum. In my view, the focus remains on UBS's outperformance amid geopolitical risks and shifting rates, though regulatory updates on capital requirements are now in the spotlight.
Forward Outlook and Key Factors to Monitor
UBS confirmed it remains on pace to wrap up Credit Suisse integration by the end of 2026, with cost savings at $11.5 billion so far and more to come. The bank intends to buy back $3 billion in shares ahead of the Q2 results, with potential to speed up depending on results, while aiming for a year-end CET1 ratio near 14%.
One thing that stands out is the asset inflows—$37 billion in GWM and $14 billion in Asset Management—which point to steady demand. For the Investment Bank, swings in Global Markets volatility and M&A activity will be crucial. Cost discipline continues, with $0.8 billion saved this quarter.
I'm watching broader factors like Swiss parliamentary reviews on foreign participation capital, interest rate trajectories impacting net interest income (NII), and credit quality via NCOs. Loan growth of CHF 40 billion to Swiss businesses and households reflects solid domestic demand. Executing well on these will drive the medium-term ROTCE path.
Tickeron’s AI Screener in My Research
In my own analysis workflow, I rely on Tickeron’s AI Screener as a powerful tool for discovering stocks and ETFs. It lets me filter thousands of assets using technical patterns, fundamentals, trends, volatility, and AI signals, with customizable options like industry, market cap, indicators, and performance metrics. This helps pinpoint trade ideas, breakouts, and opportunities far quicker than manual scans, and I've found it especially useful for contextualizing results like UBS's within its sector.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
Momentum Indicator for UBS turns negative, indicating new downward trend
UBS saw its Momentum Indicator move below the 0 level on August 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 322 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.830) is normal, around the industry mean (1.897). UBS has a moderately high P/E Ratio (18.126) as compared to the industry average of (15.307). Projected Growth (PEG Ratio) (0.869) is also within normal values, averaging (1.603). Dividend Yield (0.021) settles around the average of (0.026) among similar stocks. P/S Ratio (3.392) is also within normal values, averaging (3.937).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a major bank
Industry MajorBanks
Advertisement